Back to results
US 2026/0248751 A1Published application
Pharmaceutical oral solid dosage forms including liothyronine and levothyroxine salts and methods of making and using the same
AssigneeGenus Lifesciences Inc.
InventorsJeffrey M. Moshal, Michael Libman, Prakash Ramalingam
Life of this patent
Estimating the term…
Abstract
Pharmaceutical oral solid dosage forms including liothyronine and levothyroxine salts and methods of making and using the pharmaceutical oral solid dosage forms are disclosed.
Claims16
-134. (canceled)
A pharmaceutical oral solid dosage form comprising:
- about 7.5 μg to about 300 μg levothyroxine salt;
- about 1.75 μg to about 75 μg liothyronine salt;
- about 74% to about 96%, by weight, microcrystalline cellulose;
- and
- at least one excipient selected from a lubricant, a glidant, a diluent, a disintegrant, and a coating.
2 more elements
A pharmaceutical oral solid dosage form comprising:
- about 7.5 μg to about 300 μg levothyroxine salt;
- about 1.75 μg to about 75 μg liothyronine salt;
- about 74% to about 96%, by weight, microcrystalline cellulose;
- mannitol;
- hydroxypropyl methylcellulose;
- and
- butylhydroxyanisole.
4 more elements
Dependencies are inferred from the claim text.